Esophageal cancer
Showing 1 - 25 of >10,000
Esophageal Cancer Trial in Ramat Gan (CPAP)
Recruiting
- Esophageal Cancer
- CPAP
-
Ramat Gan, IsraelSheba Medical Center
Sep 13, 2023
Esophageal Cancer, Esophageal Tumors Trial in Boston (Prehabilitation Program)
Not yet recruiting
- Esophageal Cancer
- Esophageal Neoplasms
- Prehabilitation Program
-
Boston, MassachusettsMassachusetts General Hospital
Sep 6, 2023
Patients in Esophageal Cancer Clinical Research
Not yet recruiting
- Esophageal Cancer
- (no location specified)
Apr 14, 2023
Prevent Anastomotic Leakage After Esophagectomy Due to
Not yet recruiting
- Esophageal Cancer
- +2 more
- Eso-SPONGEĀ®
-
Barcelona, Catalunya, SpainHospital Clinic de Barcelona
Oct 20, 2023
Microbiome of Esophageal Cancer Patients and Post Esophagectomy
Recruiting
- Esophageal Tumors
-
Haifa, IsraelRambam Health Care Campus
Nov 13, 2023
Patient Participation in Lung and Esophageal Cancer Patients
Recruiting
- Lung Cancer
- Esophageal Cancer
-
Guangzhou, ChinaSun Yat-sen University
Aug 25, 2023
Follow-up Strategy for Esophageal Cancer Patients
Active, not recruiting
- Esophagus Cancer
- follow-up with different time intervals
-
Guangzhou, Guangdong, ChinaJianhua Fu
Sep 13, 2023
Esophageal Tumor Metastatic, Esophageal Cancer Stage IVb Trial in Beijing (drug, biological, radiation)
Recruiting
- Esophageal Neoplasm Metastatic
- Esophageal Cancer Stage IVb
- TP (Paclitaxel with cisplatin or carboplatin) or PF (Fluoropyrimidine with cisplatin or carboplatin) regimen depended on investigator's choice.
- +3 more
-
Beijing, Beijing, ChinaCancer hospital, CAMS
Oct 19, 2023
Retrospective Review of Esophageal Cancer at MSKCC
Recruiting
- Esophageal Cancer
- Esophagus Cancer
- Esophagectomy
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Jan 23, 2023
Esophageal Carcinoma Trial in Nanjing (Nimotuzumab, Tigio, Concurrent radiation therapy)
Enrolling by invitation
- Esophageal Carcinoma
- Nimotuzumab
- +2 more
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023
Esophageal Cancer Trial in Sohag (Minimally Invasive Surgery for Esophageal Cancer)
Not yet recruiting
- Esophageal Cancer
- Minimally Invasive Surgery for Esophageal Cancer
-
Sohag, EgyptSohag university
Dec 14, 2022
Esophageal Cancer Trial in Taoyuan (PET/MRI)
Completed
- Esophageal Cancer
- PET/MRI
-
Taoyuan, TaiwanLinkou Chang Gung Memorial Hospital
May 9, 2023
Esophageal Cancer Trial (Blood sample)
Not yet recruiting
- Esophageal Cancer
- Blood sample
- (no location specified)
Jan 19, 2023
Immunotherapy;Envafolimab; Esophageal Cancer Trial (Envafolimab, Abraxane, Cisplatin)
Not yet recruiting
- Immunotherapy;Envafolimab; Esophageal Cancer
- Envafolimab
- +2 more
- (no location specified)
Apr 24, 2023
Esophageal Carcinoma Trial in Shijiazhuang (toripalimab)
Recruiting
- Esophageal Carcinoma
-
Shijiazhuang, Hebei, ChinaFourth Hospital of Hebei Medical University
Aug 20, 2023
Dose to Cardiac Substructures on Survival in Esophageal Cancer
Recruiting
- Esophagus Cancer
-
Brest, FranceChu Brest
Aug 16, 2023
Esophageal Cancer Trial in Taoyuan (PET/MRI)
Completed
- Esophageal Cancer
- PET/MRI
-
Taoyuan, TaiwanLinkou Chang Gung Memorial Hospital
May 9, 2023
A Multicenter, Cross-sectional Study on Quality of Life in
Not yet recruiting
- Assessing the Current Quality of Life Status of Esophageal Cancer Patients Who Have Undergone Radical Chemoradiotherapy/Radiotherapy and Long-term Survival
- questionnaire investigation
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Apr 24, 2023
Esophageal Cancer Risk Registry
Recruiting
- Esophageal Cancer
- +4 more
- Survey of client health, personal habits, family history
- +3 more
-
Pittsburgh, PennsylvaniaDepartment of Cardiothoracic Surgery
Jan 23, 2023
Symptoms Based on Patient-reported Outcomes in Immunotherapy for
Not yet recruiting
- Esophageal Cancer
- +2 more
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Aug 24, 2023
Esophageal Cancer, Radiation Therapy, Immunotherapy Trial in Taizhou (Toripalimab, Tegafur, IMRT)
Recruiting
- Esophageal Cancer
- +3 more
- Toripalimab
- +2 more
-
Taizhou, Zhejiang, China
- +1 more
Apr 15, 2023
Esophageal Cancer Trial in Weihui, Suining, Beijing (Utidelone and anlotinib)
Recruiting
- Esophageal Cancer
- Utidelone and anlotinib
-
Weihui, Henan, China
- +2 more
May 10, 2023
Esophageal Cancer Trial (Adjuvant Immunoradiotherapy (ARM1) and Adjuvant Immunotherapy (ARM1B), Adjuvant chemoradiotherapy)
Not yet recruiting
- Esophageal Cancer
- Adjuvant Immunoradiotherapy (ARM1) and Adjuvant Immunotherapy (ARM1B)
- Adjuvant chemoradiotherapy
- (no location specified)
Dec 19, 2022
Postoperative Pulmonary Infection in Esophageal Cancer
Completed
- Esophageal Neoplasms
- Pneumonia
- (no location specified)
Feb 13, 2023